U.S (New York) – Report Ocean has recently published a comprehensive research report titled “U.S. Cardiac Resynchronization Therapy Market” Research Report 2023-2031. This report delves deep into the market and offers valuable insights into (Key Market Trends, Emerging Technologies, Market Drivers and Challenges of the Industry, Regulatory Policies), company profiles of key players, and their strategies. With over 100+ market data tables, pie charts, graphs, and figures, this global market study is now available. The report provides a thorough evaluation of the market, (Encompassing Future Trends, Current Growth Factors, Expert Opinions, Factual Information), and industry-validated market data, with a forecast extending until 2031.
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in geriatric population along with rise in prevalence of cardiovascular diseases (CVDs), increase in technological advancements in the CRT pacemakers and CRT defibrillators, and rise in healthcare expenditure in the U.S. are some of the major factors that boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), it is estimated that 12.1 million individuals will have atrial fibrillation (AFib) by 2030 in the U.S. In addition, the CDC reported that approximately 6.2 million adults in the U.S. are suffering from heart failure. One patient dies every 36 seconds in the U.S. from cardiovascular disease.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1621
Cardiac resynchronization therapy (CRT) is a treatment prescribed to help heart beat with the correct rhythm. CRT uses a pacemaker for restoration of the normal timing pattern of heartbeat. It is a procedure to implant a device in the chest to make heart’s chambers contract proficiently. Cardiac resynchronization therapy is traditionally a treatment for patients who experience heart failure and then develop an arrhythmia. Cardiac resynchronization therapy offers applications in the intraventricular dyssynchrony, interventricular dyssynchrony, and atrioventricular dyssynchrony.
Heart disease is the leading cause of death for men, women, and individuals of most racial and ethnic groups in the U.S. In addition, about 655,000 Americans die from heart disease every year, which is one in every four deaths. In contrast, the presence of stringent regulations for CRT devices and high cost of CRT therapy in the U.S. are anticipated to impede the market growth over the assessment period. The U.S. cardiac resynchronization therapy market is segmented into type, application, and end user. By type, the market is categorized into CRT pacemaker and CRT defibrillator. Pacemaker is a small electronic device, implanted below the collarbone and are connected to the heart with wires or leads to the right chambers of the heart. The CRT defibrillator segment is expected to dominate the market over the forecast period due to rising adoption of CRT defibrillators over CRT pacemakers and the launch of technologically advanced CRT defibrillators.
On the basis of application, the U.S. cardiac resynchronization therapy market is divided into intraventricular dyssynchrony, interventricular dyssynchrony, and atrioventricular dyssynchrony. Intraventricular dyssynchrony is the principal factor responsible for contractile dysfunction, the one most affected by and most predictive of response to resynchronization therapy. The intraventricular dyssynchrony segment spearheaded the market in 2019 in terms of revenue attributed to comparatively higher incidence of intraventricular dyssynchrony among patients with heart failure and left bundle branch block. Interventricular dyssynchrony refers to the discordance between the times of right ventricular (RV) and left ventricular (LV) contraction, or delay in segmental wall motion. Atrioventricular (AV) dyssynchrony occurs when there is an unfavorable difference in timing between atrial and ventricular contractions. It is a delay in the normal sequential AV contraction, due to delayed conduction through the AV node. This refers to abnormal timing of contraction of the left atrium (LA) with respect to the LV impairs cardiac function.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1621
By end user, the U.S. cardiac resynchronization therapy market is segregated into hospitals, ambulatory surgical centers, and specialized cardiac treatment centers. The hospitals segment is anticipated to lead the market throughout the forecast period owing to higher number of CVDs performed along with rise in adoption of cardiac resynchronization therapy devices in the hospital settings. On the other hand, the specialized cardiac treatment centers segment is expected to witness significant market outlook during the study period as it provides diagnostic and treatment services for patients suffering from heart diseases with the assistance of an integrated medical team.
The cardiac resynchronization therapy market is highly competitive in nature, as major players in this vertical are concentrating on growth strategies such as product launches, mergers and acquisitions (M&As), partnerships and collaborations to gain competitive advantage. For instance, in June 2018, MicroPort Scientific Corporation received approval by the Japanese Pharmaceutical and Medical Devices Agency (PMDA) for PLATINIUM 4LV SonR CRT-D cardiac resynchronization device and the associated SonRtip lead featuring the innovative SonR technology. The SonR system uses an innovative contractility micro-sensor embedded in the SonRtip lead to assess the patient’s left ventricular contractility and optimize the cardiac resynchronization therapy response in heart failure patients.
According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1621
KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the U.S. cardiac resynchronization therapy market size along with the current trends and future estimations to elucidate the imminent investment pockets
– It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
– A comprehensive analysis on country assists to understand the country market and facilitate the strategic business planning and determine prevailing opportunities
– The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the U.S. cardiac resynchronization therapy market growth
List of key players profiled in the report
– Medtronic plc
– Abbott Laboratories
– BIOTRONIK SE & Co. KG
– Boston Scientific Corporation
– Lepu Medical Technology (Beijing) Co., Ltd.
– LivaNova PLC
– MEDICO S.p.A.
– MicroPort Scientific Corporation
– OSCOR Inc.
– Osypka Medical GmbH
List of other players in the value chain (profiles not included in the report):
– Cook Group Incorporated
Request To Download Sample of This Strategic Report:- : https://reportocean.com/industry-verticals/sample-request?report_id=AMR1621
KEY MARKET SEGMENTS
By Type
– CRT Pacemaker
– CRT Defibrillator
By Application
– Intraventricular Dyssynchrony
– Interventricular Dyssynchrony
– Atrioventricular Dyssynchrony
By End User
– Hospitals
– Ambulatory Surgical Centers
– Specialized Cardiac Treatment Centers
Why Choose Report Ocean Reports?
Uncovering business opportunities: Our market research reports are invaluable for analyzing potential markets and identifying new product opportunities. They provide insights into customer needs, preferences, and attitudes, as well as facilitate product and service comparisons.
Gaining a clear understanding of your customers: Market reports offer a comprehensive understanding of customers’ needs and desires, empowering your company’s marketing department to enhance products, reduce costs, and improve promotional strategies based on this valuable information.
Data-driven insights: Our market research encompasses a broad spectrum of activities, including market size determination, demand forecasting, competitor analysis, and price monitoring. All these aspects are quantified and measurable, providing you with tangible data-driven insights that enable informed decision-making.
Key Highlights:
Revenue and Sales Estimation: Our reports present historical revenue and sales volume data, which is further triangulated using top-down and bottom-up approaches to forecast the complete market size. Additionally, the report provides estimates for key regions, along with well-recognized types and end-use industries. Macroeconomic factors and regulatory policies are also considered for industry evolution and predictive analysis.
Five Forces Analysis: To enhance market understanding, we conduct a comprehensive five forces analysis that includes evaluating the bargaining power of buyers and suppliers, the threat of new entrants, the threat of substitutes, and the level of rivalry within the market.
Competition: We study leading players in the industry based on their company profile, product portfolio, capacity, product/service pricing, sales performance, and cost/profit analysis.
Demand & Supply and Effectiveness: Our reports provide insights into distribution channels, production, consumption, and, if applicable, import and export activities.
Request full Report:https://reportocean.com/industry-verticals/sample-request?report_id=AMR1621
About US Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Email: sales@reportocean.com
Visit our news website: https://reportocean.com